Prothena reported $465K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Akebia Therapeutics AKBA:US $ 0M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
ALKERMES ALKS:US $ 1.65M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Amgen AMGN:US $ 31989M 112M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Exelixis EXEL:US $ 0.32M 0M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Macrogenics MGNX:US $ 0.61M 0.01M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Prothena PRTA:US $ 0.46M 0.02M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 85K 0
YTE INCY:US $ 0.22M 0M